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The measurement of access recirculation is important as its
presence can significantly decrease the efficiency of a hemodialysis
treatment [1]. Furthermore, detecting the presence of significant
access recirculation may lead to the finding of vessel stenosis
which may be correctable by intervention such as angioplasty
which in turn may prolong the useful life of that particular
vascular access [2]. The classical method for measuring recircula-
tion is by comparing the blood ureas taken simultaneously from
the arteriovenous lines of the dialysers and from the peripheral
circulation. Recirculation is then defined by the formula:
P-AR= x100
where A represents the urea content of the dialyzer arterial line,
V the urea content of the dialyzer venous line and P the urea
content of a peripheral vein. Thus, when recirculation is absent,
the urea in the peripheral vein and the arterial line should be
equal (P — A = 0). Unfortunately, there are inherent inaccura-
cies in this method. During hemodialysis, compartment disequi-
librium can occur leading to the finding of a venous urea
concentration in the arm opposite to the one providing blood
access that is higher than the urea concentration of the blood
entering the dialyzer (arterial supply) even when access recircu-
lation has deliberately been prevented by occluding the access
graft between the access needle sites [3]. Any degree of cardio-
pulmonary ("long loop") recirculation will also reduce the urea
concentration of dialyzer inlet blood (using a peripheral limb
access, not central venous) as compared to that of blood leaving
the systemic tissue compartment and therefore, access ("short
loop") rccirculation may be erroneously indicated [4, 5]. Should
the above problems be minimal, then this method of calculating
access recirculation is still inaccurate at low levels of recirculation
(10% or less) because of the standard error in the biochemical
estimation of urea itself [6]. Finally, the measurement of access
recirculation by the three urea method does not give an instanta-
neous result. There is, therefore, a need for a method which will
give highly accurate and almost instantaneous measurement of
access recirculation that can be applied to the busy dialysis clinic.
Such a method is described using a device called the hemody-
namic recirculation monitor (HDM).
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Methods
The hemodynamic recirculation monitor
The hemodynamic recirculation monitor (HDM) is a non-
invasive electronic device using magnetic principles which will
measure differential conductivity between arterial and venous
blood flows in a blood tubing set. The device employs a non-
invasive sensor which is clamped around both the venous and
arterial lines of the dialysis blood tubing set and the sensor
contains two magnetic cores: (a) an excitation core which induces
a magnetic field across the blood in the tubing; and (b) a sense
core which senses the inductive reactance of blood within the
tubing set. The output sensor of the sense core is conditioned and
amplified on analogue circuitry and then output via analogue to
digital converter for processing and display. The signal output by
the sensor is a measure of the difference in conductivity between
the blood flows in the arterial and venous lines of the tubing set.
The digitized output is processed through a software algorithm
which detects and quantifies changes from the baseline differential
conductivity measurement. The access recirculation measurement
is effected by injecting a small bolus of hypertonic saline into the
venous blood line, causing a positive change in the differential
conductivity of the venous blood line with respect to the arterial
blood line in the sensor, and thereby creating a detectable and
quantifiable positive change from the baseline differential conduc-
tivity. The presence of access recirculation causes a portion of the
venous injected bolus to recirculate through the sensor by way of
the arterial blood line. Recirculation in the arterial blood line
causes a negative change in the differential conductivity of the
venous blood line with respect to the arterial blood line, which is
again detectable and quantifiable. The ratio of the second quan-
tified signal to the first provides an accurate measurement of
access recirculation.
A schematized diagram of the HDM is shown in Figure 1. This
Figure indicates that the blood tubing lines to and from the
patient are brought into contact with each other and crossed over
within the conductivity cell enclosure. The blood tubing set thus,
has to be modified by the insertion of toroids ("blood loops") into
each of the lines (Fig. 2). For these studies the toroids were
manufactured from the same material as the standard set, man-
ufactured directly into the tubing set, and sterilized with the set by
COBE Renal Care (Denver, CO, USA), and disposed of with the
set after a single use. To enable the measurement of differential
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conductivity between the venous and arterial lines, the conductiv-
ity cell closure is clamped around both the venous and arterial
toroids during testing.
HDM — The test
A bolus of hypertonic saline (1 ml of 23.4% NaCl) is injected
into the dialyzer venous line as a conductivity "tracer." The
duration of injection is approximately one second; precision is not
required (Appendix A). The "tracer" enters the patient and if
access recirculation is present, a percentage of the "tracer" will
immediately reappear in the arterial line and is detected and
quantified in approximately one minute. The site of injection into
the venous line is before the conductivity cell enclosure as shown
in Figure 1. Figure 3 depicts the signal obtained from the "tracer"
going to the patient (positive deflection) and returned in the
arterial line (negative deflection) as seen on the output screen of
the device. From these deflections, the percentage of access
recirculation can be instantly computed. The mathematics involve
five separate steps accomplished after the completion of data
collection and digitization. The first step is to examine the test
signal and ensure that the data collected are within the perfor-
mance parameters of the device. This involves computing some
statistical parameters on the test signal, which precludes the
reporting of an erroneous access recirculation measurement. For
example, if the signal is excessively unstable due to some form of
external interference, the device reports an interference error and
recommends that a second measurement be taken.
Assuming that the test data are within parameters, the second
step is to detect the precise start and stop time of the bolus and
access recirculation (if any) signals. This is achieved using a digital
signal detection algorithm designed to indicate deviations from
the baseline differential conductivity measurement.
Thirdly, the differential conductivity measurements within the
detected signals are converted to measures of differential saline
concentration, since the access recirculation measurement is
actually a volumetric ratio of the quantity of saline recirculated to
the quantity of saline injected. Additionally, laboratory analysis
indicates that the relationship between differential conductivity
and differential concentration is non-linear, thereby requiring the
use of a transfer function to ensure an accurate measurement.
The bolus and access recirculation signals are then quantified
by integrating the differential concentration values output by the
transfer function, over the start and stop times for each signal
stored by the digital signal detection algorithm.
The access recirculation is calculated by computing the ratio of
the access recirculation integral to the bolus injection integral.
This ratio, expressed as a percentage, is displayed to the operator
as the access recirculation percentage.
A detailed description of the theory and algorithm employed is
given in the Appendix.
From To ArchItecture Block DiagramPatient Patient
Fig. 1. Schematized diagram of the hemodynamic recirculation monitor (HDM).
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Fig. 2. Blood tubing modification by insertion of toroids into the lines.
In vitro experiments
An in vitro circuit which contained 0.9% saline or outdated
human bank blood circulated from a reservoir at a flow rate of 250
mi/mm was prepared. One milliliter of "tracer" was injected into
the venous port of this circuit and immediately following, variable
amounts of "tracer" were injected into the arterial port to
simulate access recirculation of 5, 10, 15, 20 and 25% (such as, for
10% recirculation, arterial port injected amount = 0.1 cc) The
access recirculation was estimated by the HDM was then recorded
for comparison.
Clinical studies
One thousand one hundred and two (1,102) recirculation
measurements were made on 61 randomly-selected patients un-
dergoing routine dialysis over a two week period. These patients
had various forms of dialysis access [A-V fistulae (N = 27),
Gore-Tex grafts (WL Gore and Associates, Flagstaff, AZ, USA)
(22), subclavian veno-venous catheters (5), PermCath veno-ve-
nous catheters (Quinton, Seattle, WA, USA) (7)]. On occasions,
the access was deliberately reversed (such as, with suhclavian
catheters connecting arterial line to dialyzer venous line and vice
versa). Furthermore, during the dialysis procedure, the blood
flows were varied deliberately (150 to 450 mi/mm) to examine the
influence of this on the presence, absence and degree of access
recirculation. Multiple measurements (1 — it)) were made during
each patient dialysis session and the same patient may have been
studied on two or maximally three occasions. Simultaneous mea-
surements of access recirculation by the three urea method but
utilizing the "stop flow" technique (see below) were also carried
out on 88 occasions.
In addition to the above, eight studies were carried out on one
patient who had two separate blood accesses (Gore-Tex graft
brachial artery to axillary vein on both sides). This patient was
cannulated with the arterial needle in one access site and the
venous needle in the other, thus ensuring there would be zero
access recirculation. Another patient, who had just clotted the
main limb of his arteriovenous fistula hut still could be cannulated
using a collateral vessel, was studied on six occasions.
Finally, "ground truth" tests were carried out on patients who
previously had been found to have zero recirculation, and on
these occasions, 1 ml of "tracer" was injected into the venous port
immediately followed by 0.1 ml "tracer" into the arterial port to
simulate 10% recirculation. Forty-three of these tests were carried
Out on sixteen patients.
Access recirculation by urea method
Blood samples were first taken from the dialyzer arterial (A)
and venous (V) blood lines, the blood pump was stopped and the
arterial line disconnected from the arterial access needle after its
attached tubing was clamped. Flow was allowed to continue
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Fig. 3. Plot of the digitalized 11DM sensor output
with respect to time. The zero mark on the X-
axis represents the start time of the test. The
first five seeoods of data are used to oormalize
the rest of the trial by establishing a baseline
differential conductivity measurement for the
given patient. The rest of the data points are
referenced to this baseline or zero point. The
first deviation from the baseline represents the
change in differential conductivity resulting
from the bolus injection into the venous line of
the blond tubing set. The vertical lines to the
left and right of the signal are indications of the
time at which the digital signal detection
algorithm identified the start and finish of this
deviation from the baseline. The second
deviation from the mean is a result of some of
the injected saline being recirculated into the
arterial tubing line via the patient's access. The
vertical lines arc again an indication of the
signal detection algorithm's calculation of the
start and end of this signal. A description of the
algorithm for calculating access recirculation
from the information depicted in this figure is
in the Appendix.
though fhe access. Thirty seconds after stopping the blood pump
5 ml of blood was withdrawn via the arterial access needle and
discarded, and then a further 3 ml of blood was taken to represent
the peripheral blood (P). The three samples were sent for
estimation of urea concentration and the value for recirculation
calculated from the formula:
P—AR=— x100P—V
Safety 2f lest
Twenty-three point four percent (23.4%) saline has a concen-
tration of 4,000 mmol/liter Na, that is, 4.0 mmol Na (and CF)
are injected into the venous line with each experiment. In these
studies, not more than ten estimations were taken during a four
hour hemodialysis session giving a total input of 40 mmol Na
maximum to each patient, which can easily be dialyzed off during
the treatment. Hypertonic saline (17% to 23.4%) has been safely
used for many years in the treatment of cramps and hypotension
during dialysis with volumes of 5 to 10 ml given per bolus injection
[7j. Each patient studied gave informed consent prior to the test.
Results
In vitro experiments
Table 1 shows the results of the in vitro studies giving the mean
and so of the series (N = 10 for each) of recirculation measure-
ments made when the system was made to simulate 5, 10, 15, 20
and 25% recirculation both with saline and with blood. The results
show considerable accuracy in the measurement. There is, how-
ever, a small so in the results, particularly so with experiments
involving outdated human blood, such as 21.8 3.15% (mean
so) for the 20% simulated recirculation.
Table 1. Results of recirculation measurements by the HDM when a
range of recirculation (5% to 25%) was stimulated in an in vitro circuit
containing either saline or blood
Trial
N=10
Recirculation percentage
5 10 15 20 25
Saline
Blood
mean
+
so
mean
so
5.42
0.25
4.57
0.51
10.62
0.30
12.03
2.04
14.89
0.50
16.43
1.55
21.39
0.62
21.80
3.15
26.09
1.38
—
—
Clinical studies
Figure 4 shows the number of separate patient sessions (note: a
given patient may have been studied on more than 1 session)
where recirculation measurements were made on patients with
various forms of vascular access and the number in whom access
recirculation was detected per session. These studies were per-
formed during routine dialysis with the usual blood flow rate that
the patient had used (range 250 to 375 mI/mm). These patients
were randomly selected and the data indicates that very few
patients had any access recirculation (such as 2 patients out of 27
using a natural A-V fistula and I of 3 patients using a subclavian
vcnn-venous catheter when flow was not reversed). In no case was
recirculation detected with the use of a Gnre-Tex graft (22 times
with 22 patients) or a PermCath veno-venous catheter (11 times
with 7 patients). Those three patients (2 with A-V fistulae, 1 with
subelavian) who had recirculation were then studied on repeated
occasions during the same session and on subsequent sessions for
a total of 17 and 6 measurements, respectively, for the A-V fistula
and subclavian catheter. Figure 4 also shows the range and mean
values for recirculation (%)so obtained. On the other hand, when
the flow in the PermCath or subclavian catheters was reversed, the
expected recirculation was detected (12 out of 12 times in 7
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Fig. 4. Total number of patient sessions versus
number with access recirculation by access type.
Patients with demonstrable access recirculation
were studied on repeated occasions; the range
and mean values for recircutation (%) for these
are shown (1 sigma = 1 SD). Symbols are: ()
number tested; (U) number with access
recirculation.
Fig. 5. Total number of patient sessions versus
number with access recirculation by access type
(high flow rate study). Patients with
demonstrable access recirculation were studied
on repeated occasions; the range and mean
values for recirculation (%) for these are shown
(1 sigma = 1 SD). Symbols are: () number
tested; (U) number with access recirculation.
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PermCath patients; 15 out of 15 times in 5 patients with subcla-
vian catheters). Again multiple recirculation measurements were
made and the range and mean values for recirculation (%) are
shown together with the numbers of measurements made (Fig. 4).
Figure 5 shows what happened in some of the same patients when
the blood flow rate was deliberately increased to 450 mI/mm (in
the others it was either impossible or not attempted). Now 6 of 15
patients with A-V fistu!ae had detectable recirculation, as had all
of the patients with PermCath and suhclavian catheters whether
reversed or not. Interestingly, in the four studies carried out on
patients using Gore-Tex grafts, still no access recirculation was
detected. Those patients who did demonstrate recirculation were
studied, as before, on repeated occasions during the same session
and on subsequent sessions and the range and mean values for
recirculation (%) together with the numbers of measurements are
also shown (Fig. 5). The total number of occasions when access
recirculation was demonstrated during these first studies (Figs. 4
and 5) was 182; the other 920 studies (by multiple measurements
on given patients) showed zero recirculation. Figure 6 shows the
effects of varying the blood flow rate for 6 patients selected from
the high flow rate study (Fig. 5), 5 of whom were found to have
access recirculation (varying from 2% to 42% when the blood flow
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Fig. 6. Access recirculation versus pump rate setting (selected patients from
high blood flow rate study).
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Trial number HDM recirculation % BUN recirculation %
1 0.00 1.60
2 0.00 3.16
3 0.00 2.13
4 0.00
5 0.00
6 0.00
7 0.00
8 0.00
Mean 0.00 2.30
Repeated measurements of recirculation using the HDM in a patient
with 2 dialysis accesses and with the arterial needle in one and the venous
needle in the other thus eliminating the possibility of access recirculation.
On each of 8 occasions, the HDM detected zero recirculation, in 3 of the
8 simultaneous measurements by the urea method were made and some
recirculation was detected.
Trial number HDM recirculation % BUN recirculation %
1 69.67 73.41
2 97.84 92.78
3 78.44
4 81.95
5 81.81
6 79.16
7
8
Mean 81.48 83.10
rate was at least 400 mI/mm). In these patients, repeated mea-
surements were done and access recirculation was studied while
varying the blood flow from 150 to 450 mi/mm. Patients #1, #2
and #3 exhibit a threshold blood flow where access recirculation
occurs and then progressively increases as the blood flow is raised.
Three patients (#4, #5 and #6) show very little recirculation even
at high blood flow rates. Patient #1 had only recently commenced
hemodialysis treatments and had a forearm A-V fistula. No access
recirculation was suspected as blood flow rates were good and at
that point, no urea kinetic measurements had been made on him.
He was randomly chosen to have access recirculation measured as
part of the early study and recirculation in excess of 40% with
blood flow rates of 300 to 350 ml/min was found and confirmed on
repeated occasions. The subsequent studies showed that even at
blood flow rates of 200 mI/mm, he still recorded approximately
7% access recirculation. Angiography was subsequently carried
out and a very tight stenosis at the venous anastomosis was
detected and successfully angioplastied.
Table 2 shows the results of the measurement of recirculation
by the HDM on eight separate occasions during two dialyses on
the patient utilizing two accesses. No access recirculation was ever
detected, On the other hand, on three occasions, simultaneous
estimations of recirculation by the urea method were carried out
and in each case, some recirculation was detected. Table 3 shows
that on six occasions, very high levels of recirculation were
detected in the case of the patient who had a clotted fistula, but
90.00
80.00
70.00
60.00
50.00
40.00
30.00 +
20.00 --
10.00
0.00
—10.00 -L-—
dialysis was just possible using a collateral vessel. It should be
noted that on two occasions, good correlation was obtained with
recirculation estimates using blood ureas.
Figure 7 shows the results of 88 simultaneous measurements of
recirculation by the HDM and the urea measurements. While an
excellent linear correlation is obtained (r = 0.92) it must be noted
that on 61 occasions, the HDM detected 0 to 2% recirculation. At
this level, the range of recirculation results using ureas was —8%
to + 13%. Information regarding the accuracy and precision of
recirculation values obtained by the HDM relative to the urea
method were obtained from six patients. These were six patients
in the clinical trial who exhibited access recirculation, and had
equal numbers of HDM [61 and urea [3] tests administered.
Utilizing Bartlett's test for homogeneity of variance [8], it was
determined that, for N = 6, the variances of six patients' HDM
tests were equal at the 0.01 level of significance. This demonstra-
tion of equal variance allows pooling of the HDM results from the
six trial patients. Figure 8 shows the normal distribution curves of
the HDM and urea access recirculation measurements for the six
test patients. The curves are interesting in two respects. First, it is
seen that the mean of the HDM measurements (10.94%) is within
the one SD of the means of the urea measurements (14.32
6.75%). This further evidences the correlation of the urea and
HDM means demonstrated in the simple linear regression anal-
ysis (Fig. 7). Secondly, notice the height of the HDM normal
distribution curve relative to that of the urea. This is an illustra-
tion of the fact that the HDM SD is significantly less than that of
the urea and demonstrates the repeated precision of the HDM
measurements.
The results of the "ground truth" studies where 10% access
recirculation was simulated in patients previously proven to have
no recirculation showed the mean recirculation detected by the
HDM to be 10.51 1.9% (mean SD). This gave a 95%
Table 2. Zero recirculation test—Patient with two accesses
Margin of HDM insensitivity = 0—2%
(I)
a>
z
Table 3. Special case—Clotted access using collateral vessel
—10.00 0.00 10.00 20.00 30.00 40.00 50.00 60.00 70.00 80.00 90.00
HDM result
Fig. 7. Access recirculation results as obtained by the HDM plotted against
those obtained by urea measurements (r 0.92,' slope = 0.878; N = 88).
Repeated measurements of access recirculation were made in a patient
whose blood access had clotted but in whom cannulation was possible
using a collateral vessel. The expected high values for recirculation were
detected by both the HDM and the urea methods.
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Fig. 8. The precisian and accuracy of recirculation measurements by the
HDM relative to those obtained by the urea method: a comparison of the
normal distributions of recirculation values by these 2 methods in a 6 patient
sample. Symbols are: (—) HDM normal distribution; ( ) urea
normal distributiun. Mean HDM = 10.94%; sigma HDM = 2.63%; mean
urea = 14.32%; sigma urea = 6.75.
confidence range of 9.9 < mean < 11.07 (Student's t-test) and
1.86 < Sn < 2.86 (chi square).
Safely of test
No local discomfort at blood access sites was noted nor any
systemic upset was recorded by any patient during these studies.
Discussion
These data show that the HDM is a very reliable and rapid way
to measure access recirculation. The methodology does, however,
require modification of dialyzer blood lines by the insertion of
toroids ("blood loops") into each of the lines. In these studies
CUBE Renal Care (Denver, CU, USA) modified their standard
lines to include the toroids as integral parts of the lines. Thus,
there was no concern about breaches in sterility nor the potential
for blood leakage that might have occurred if standard lines had
to be cut and the toroids inserted. The length of the blood tubing
between the magnetic sensors and the blood access is also
important (Appendix), as is the positioning of the toroids in the
lines. These factors would need to be considered should toroids be
manufactured for the insertion into any commercially available
blood line. The methodology also requires the injection of 1 ml of
hypertonic saline (23.4%) into the venous blood line over approx-
imately one second. In these studies up to 10 separate tests were
performed in individual patients over the course of a single
four-hour hemodialysis with intervals between testing as small as
three minutes. No side effects of these repeated injections, either
local to the access site or systemic, were noted. Larger volumes (5
to 10 ml) of 23.4% saline have been used to treat dialysis induced
cramps and hypotension [I without adverse side effects, although
the saline is usually given over 30 to 60 seconds, considerably
longer than the times used with the HDM methodology. Thus,
peak sodium concentrations local to the endothelium of a blood
vessel (for example, in an A-V fistula) may be less. It is difficult to
calculate with accuracy this peak sodium concentration but an
assumption can be made. At the injection site 1 ml of saline with
a Na concentration of 4000 mmol/liter is mixed with the blood in
the blood tubing over approximately one second. Twenty centi-
meters downstream from the injection site are the toroids (Fig. 1)
where the differential conductivity between the arterial and
venous blood flows is sensed. The maximum differential conduc-
tivity recorded during these experiments would indicate that the
blood/saline bolus at the venous toroid had a maximum Na4
concentration of 1200 mmol/liter. From the toroids there is a
further 150 cm of venous blood tubing to the blood access site and
the same distance from the blood access back to the toroids via
the arterial blood tubing. If there was 20% access recirculation
then the differential conductivity measured at the arterial toroid
would indicate the blood/saline bolus to now have a Na concen-
tration of approximately 200 mmol/liter. If we assume a continu-
ous dilution of the saline injected by blood, approaching equilib-
rium at 140 mmol/liter Na concentration and a logarithmic or
inverse square decay over the distances given, then the approxi-
mate sodium concentration of the blood/saline bolus at the blood
access site would be 500 mmol/liter. The time exposure of this
blood/saline bolus (at this concentration) to local endothelium
would be minuscule, and thus is likely harmless. While the authors
do not believe repeated injections over time of this hypertonic
saline are likely to cause endothelial damage (and problems such
as fistula clotting), this possibility will be given ongoing scrutiny.
The results indicate that the methodology is sensitive, for it
demonstrated access recirculation, as would be expected in all
catheters with their blood lines reversed. It is clearly accurate as
shown by the clinical "ground truth" tests. It would appear that
these seem to be more accurate than the original in vitro studies
that were carried out. It must be pointed out that the latter were
done at a stage of earlier development of the device and then were
used in the clinical studies, and the subsequent improved accuracy
of the device may explain the difference. The studies on the
patient with the two accesses (showing xero recirculation), sup-
port the contention that the HDM is "specific" (not going to give
false-positives). The HDM would clearly be of value in routine
care as it is safe and very rapid, it takes less than one minute to do
the test and have the result. The HDM could become the "gold
standard" for studies on the physiology of access recirculation,
clinical trials involving intervention, etc., especially so because the
urea method is inaccurate. There are other methodologies being
developed to measure recirculation employing, for example, ul-
trasound Doppler [9] and thermodilution 1101 techniques, which
may well be valuable clinically but, so far, there are no published
data on their accuracy. Therefore, any comparative comments are
currently unjustifiable. This study confirms the observations of
Hester, Curry and Bower [6] showing the inaccuracy of the urea
method at low levels of recirculation, which they indicated was
mainly due to imprecision in the actual measurement of the urea.
The methodology employed in the blood sampling for the urea
method (by "stop flow" technique) in this study was designed to
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minimize the other problems potentially confounding the recircu-
lation result: (a) compartment disequilibrium (by taking the
"peripheral vein" sample from the arterial access needle and not
from another site, such as "opposite limb"); and (b) cardiopul-
monary recirculation (by sampling 30 seconds after the temporary
cessation of dialysis).
These observations provide areas for future study. The possi-
bility that all peripheral types of access (such as Gore-Tex grafts,
A-V fistulae) have a "threshold" flow rate beyond which recircu-
lation will occur (Fig. 6) is perhaps not unexpected, but it is likely
that defining values for the "threshold" will be useful in predicting
which accesses are at risk for clotting and hence, which require
investigation. Studies are also required to define by exactly how
much does the degree of recirculation reduce the efficiency of the
dialysis treatment at different blood flow rates, and how the
dialysis prescription should be redefined knowing the "threshold"
for recirculation and the relationship between the degree of
recirculation and the dialysis blood flow rate. Finally, in some
patients "long loop" or cardiopulmonary recirculation was ob-
served at levels detectable by the HDM. HDM separates cardio-
pulmonary recirculation from access recirculation based on the
time delay between the start of the bolus and the start of any
recirculation signal. This is done by estimating the flow rate in the
tubing set based on the integral value of the bolus injection signal.
Using the flow rate estimate, and knowing the volume of the
blood tubing set, the expected time delay to access recirculation is
outer bounded. Any recirculation signal started after this outer
boundary is identified as cardiopulmonary recirculation. It is
possible to modify the HDM to specifically measure cardiopul-
monary recirculation, and this will also be an area for future study.
Reprint requests to Dr. Robert Lindsay, Victoria Hospita1 375 South Street,
London, Ontario, Oanada NbA 405.
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Appendix
The calculation of access recirculation by the hemodynamic
recirculation monitor (HDM) is based on a flow volume analysis
of the injected hypertonic saline bolus. The recirculation equa-
tion, in its simplest form is:
where:
R = l00(QtCaIQvc) (1)
R = access recirculation percentage
Qa = flow rate in the arterial line of the blood tubing set
C. = saline concentration in the arterial line of the blood
tubing setQ = flow rate in the venous line of the blood tubing set
C, = saline concentration in the venous line of the blood
tubing set
The accuracy of the result relies critically on the device's ability to
quantize saline concentration as it passes through the sensor.
The quantization process begins with the collection, and digi-
talization, of sensor output throughout the duration of the test.
The sensor outputs a voltage that varies with the differential
conductivity between the arterial and venous tubing set lines. The
processor acquires and digitizes this data and saves it as a series of
time-voltage ordered pairs. Once the data collection begins, and
before the saline tracer injection, the device establishes the
baseline differential conductivity of the arterial and venous blood
by determining the mean voltage being output from the sensor.
The baseline may vary from patient to patient due to differing
physiology and machine parameters, but is constant for a given
patient assuming that the machine settings are not changed during
the collection of data. This baseline serves as a reference for
normalizing the entire test curve.
As depicted in Figure 3, the injection of the saline trace causes
a change in the voltage output of the sensor. This is due to the
change in the differential conductivity between the arterial and
venous blood flows resulting from the introduction of the higher
conductivity saline in the venous tubing line. Again referring to
Figure 3, any saline which enters into the arterial tubing line
through access recireulation also causes a change in the voltage
output of the sensor. The voltage change is also due to the change
in differential conductivity between the arterial and venous blood
flows, only in this ease it is resulting from the recirculation of the
higher conductivity saline that was introduced into the venous
tubing line. The direction of the recirculation voltage change is
opposite to that of the venous voltage change since the saline is
passing through the sensor in opposite directions. The length of
the tubing set is designed to preclude recirculated saline from
entering the sensor before the injected saline has completely
passed through the sensor. This prevents signal or event overlap at
all specified pump rates (200 to 500 mI/mm).
The next critical step in the algorithm is detecting the times at
which the injected bolus and access recirculation voltage changes
begin and end. The injection and recirculation events are identi-
fied using a signal detection algorithm. The times of the signal
detection are annotated in Figure 3 as vertical lines on the voltage
versus time graph.
Since the resolution is based on the flow volume analysis
equation 1, the device must transfer the differential conductivity
measurement output from the sensor to a measure of differential
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Fig. 9. The transfer function or relationship between the differential concen-
tration of saline at 37°C and the output voltage at equilibrium as measured by
the HDM. The curve is the fIt of experimental data points and has a mean
squared error of < 1.
concentration of saline with respect to time. The transfer relies on
the experimentally determined relationship between saline con-
ductivity and saline concentration at 37°C.
The relationship between the voltage output from the HDM
sensor, and the differential concentration has been determined
experimentally to be a quadratic relationship of the form:
DC = a1 V + a2 V2
where:
DC = Differential Concentration of saline at time
V = Voltage output of the sensor at time
a1 = the linear coefficient of the transfer function
a2 = the quadratic coefficient of the transfer function
3 3.5 4
The transfer function was determined by circulating known dif-
ferential concentrations of saline at 37°C through the sensor and
measuring the output voltage at equilibrium. A curve was fit to the
resulting data points, and coefficients a1 and a2 were identified.
The experiment was conducted repeatedly to refine the curve fit
until the mean squared error of the curve fit data points was < 1.
The curve is shown in Figure 9.
The time-voltage pairs are transferred to time-differential con-
centration pairs so that equation 1 can be modified to read:
R = 100 (QaJ DC dt/QvJ DC dt) (2)
access recirculation percentage
differential concentration of saline
start of the bolus event
end of the bolus event
start of the access recirculation event
end of the access recirculation event
Due to the ultrafiltration process, the flow in the arterial and
venous blood lines cannot be assumed to be equal. This can,
however, be expressed as functions of the dialysis machine
parameters. HDM uses the conventions that:
Qa = Q
and
=
- °uf
where:
Q = blood pump setting (mi/mm)Q = ultrafiltration rate (mI/mm)
Therefore, the algorithm uses the following equation to calculate
access recirculation:
R = 100
(Qpj'
DC dtJ(Q — QuJ DCdt) (3)
